ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explo

【書誌情報】

ページ数：21ページ

サイズ：A4

商品番号：HBSP-9-293-066

発行日：1992/10/22

登録日：2007/12/28